Ghent University Academic Bibliography

Advanced

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients

Reinhart Speeckaert UGent, Karim Vermaelen UGent, Nanja van Geel UGent, Philippe Autier, Jo Lambert UGent, Marc Haspeslagh UGent, Mireille Van Gele UGent, Kris Thielemans, Bart Neyns and NATHALIE ROCHE UGent, et al. (2012) EUROPEAN JOURNAL OF CANCER. 48(13). p.2004-2011
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
PLASMACYTOID DENDRITIC CELLS, SINGLE NUCLEOTIDE POLYMORPHISM, REGULATORY T-CELLS, TRYPTOPHAN CATABOLISM, MALIGNANT-MELANOMA, EXPRESSION, IDO, INHIBITORS, CONVERSION, TREGS, Sentinel node, Regulatory T cell, Prognosis, Melanoma, 3-dioxygenase, Indoleamine 2
journal title
EUROPEAN JOURNAL OF CANCER
Eur. J. Cancer
volume
48
issue
13
pages
2004 - 2011
Web of Science type
Article
Web of Science id
000307884500010
JCR category
ONCOLOGY
JCR impact factor
5.061 (2012)
JCR rank
36/196 (2012)
JCR quartile
1 (2012)
ISSN
0959-8049
DOI
10.1016/j.ejca.2011.09.007
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1955528
handle
http://hdl.handle.net/1854/LU-1955528
date created
2011-11-29 11:42:11
date last changed
2013-07-09 11:09:54
@article{1955528,
  author       = {Speeckaert, Reinhart and Vermaelen, Karim and van Geel, Nanja and Autier, Philippe and Lambert, Jo and Haspeslagh, Marc and Van Gele, Mireille and Thielemans, Kris and Neyns, Bart and ROCHE, NATHALIE and VERBEKE, NATACHA and DERON, PHILIPPE and SPEECKAERT, MARIJN and Brochez, Lieve},
  issn         = {0959-8049},
  journal      = {EUROPEAN JOURNAL OF CANCER},
  keyword      = {PLASMACYTOID DENDRITIC CELLS,SINGLE NUCLEOTIDE POLYMORPHISM,REGULATORY T-CELLS,TRYPTOPHAN CATABOLISM,MALIGNANT-MELANOMA,EXPRESSION,IDO,INHIBITORS,CONVERSION,TREGS,Sentinel node,Regulatory T cell,Prognosis,Melanoma,3-dioxygenase,Indoleamine 2},
  language     = {eng},
  number       = {13},
  pages        = {2004--2011},
  title        = {Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients},
  url          = {http://dx.doi.org/10.1016/j.ejca.2011.09.007},
  volume       = {48},
  year         = {2012},
}

Chicago
Speeckaert, Reinhart, Karim Vermaelen, Nanja van Geel, Philippe Autier, Jo Lambert, Marc Haspeslagh, Mireille Van Gele, et al. 2012. “Indoleamine 2,3-dioxygenase, a New Prognostic Marker in Sentinel Lymph Nodes of Melanoma Patients.” European Journal of Cancer 48 (13): 2004–2011.
APA
Speeckaert, R., Vermaelen, K., van Geel, N., Autier, P., Lambert, J., Haspeslagh, M., Van Gele, M., et al. (2012). Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. EUROPEAN JOURNAL OF CANCER, 48(13), 2004–2011.
Vancouver
1.
Speeckaert R, Vermaelen K, van Geel N, Autier P, Lambert J, Haspeslagh M, et al. Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. EUROPEAN JOURNAL OF CANCER. 2012;48(13):2004–11.
MLA
Speeckaert, Reinhart, Karim Vermaelen, Nanja van Geel, et al. “Indoleamine 2,3-dioxygenase, a New Prognostic Marker in Sentinel Lymph Nodes of Melanoma Patients.” EUROPEAN JOURNAL OF CANCER 48.13 (2012): 2004–2011. Print.